Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CETMET: Cetuximab Regimens in Metastatic Head and Neck Cancer
NCT01830556Phase 2Unknown
- Sponsor
- Karolinska University Hospital
- Start
- Nov 2011
- Primary completion
- Nov 2013
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of KL-140 in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Karolinska University Hospital. Status: unknown.
02
Drugs
KL-140
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01830556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01830556.